25/05/2010 (Agence Europe) - On Tuesday 25 May, the European Commission approved the acquisition of the animal health assets of US company Pfizer by fellow American group Eli Lilly & Co. Eli Lilly is a research-based, global pharmaceutical company engaged in the discovery, development manufacture and sale of a range of pharmaceutical products for humans and animals. Pfizer is active in the production of vaccines for animals. The operation was examined under the simplified merger review...